# Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus

> **NCT02737891** · PHASE2 · COMPLETED · sponsor: **Saniona** · enrollment: 60 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Tesofensine/Metoprolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02737891
- **Lead sponsor:** Saniona
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-01
- **Final completion:** 2017-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02737891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02737891, "Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02737891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*